Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study

INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) prescribed long-acting muscarinic antagonist (LAMA) monotherapy remain symptomatic. This multivariable analysis of a previously reported claims-linked, cross-sectional survey assessed symptom burden measured by the COPD as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Beth, Stanford, Richard H., Hunter, Alyssa Goolsby, White, John, Essoi, Breanna, Ray, Riju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967173/
https://www.ncbi.nlm.nih.gov/pubmed/32026410
http://dx.doi.org/10.1007/s41030-019-00098-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967173/
https://www.ncbi.nlm.nih.gov/pubmed/32026410
http://dx.doi.org/10.1007/s41030-019-00098-1

Ejemplares similares